Clinical Trial Update: Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients

View source ↗

Summary

A completed clinical trial evaluated the diagnosis of invasive pulmonary aspergillosis in critically ill patients, examining survival outcomes and risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pulmonary Aspergillosis

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Survival After IPA, Risk Factors for IPA | Status: COMPLETED